Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

No-Receipt date 2024-02177 - 12/06/2024
No-Filing date 20240401360 - 12/06/2024
No-Granting date 3115623 - 17/06/2024
No-EPO application date 20708762.8 - 24/01/2020
No-EPO granting date 3914617 - 13/03/2024
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 6/2024 - 16/07/2024
Expiration date 25/01/2040
Kind of title Validation of European Patent
Legal status VALID
Priorities US201962796953 P25/01/2019/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61P 7/00
C07K 16/18
C07K 16/28
C07K 16/40
C07K 16/46

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1618735 ALEXION PHARMACEUTICALS, INC. 121 SEAPORT BOULEVARDBOSTON, MA 02210 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
4220623 PAYTON, LORI
4220624 MIX, CHRISTIAN
4220625 PRADHAN, RAJENDRA
4220626 DAMOKOSH, ANDREW
4220627 SWENSON, EUGENE SCOTT
4220628 GAO, XIANG

Representatives
CodeFirstnameSurnameAddressTownZip
3614AIKATERINISIOTOU "KATERINA SIOTOU KAI SYNERGATES DIKIGORIKI ETAIREIA"PATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257

Contact
CodeFirstnameSurnameAddressTownZipCountry
4766AIKATERINISIOTOUPATISION (28IS OKTOVRIOU) 122ATHINA (ATTIKIS)11257 GREECE

Owners History

Title Instruments

Payments history 6 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015
 
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).